Posted on July 10, 2013 by Sitemaster
According to data from a small, randomized, clinical trial published in the Journal of the American Medical Association, daily use of a supplement containing soy protein isolate for 2 years after radical prostatectomy did not reduce risk for biochemical progression of prostate cancer in high-risk patients. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: biochenical, outcome, post-surgery, recurrence, soy, supplement | 8 Comments »
Posted on June 6, 2011 by Sitemaster
Perhaps the most interesting new data from the annual meeting of the American Society of Clinical Oncology yesterday (Sunday) was a negative result from a four-arm, randomized clinical trial. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: androgen deprivation, Effexor, hot flashes, soy, venlaxafine | 3 Comments »
Posted on May 5, 2011 by Sitemaster
A new Canadian study just reported in the Journal of Clinical Oncology has failed to find any significant benefit from the use of vitamin E, selenium, and soy protein supplements in the prevention of prostate cancer. … READ MORE …
Filed under: Diagnosis, Prevention, Risk | Tagged: HG-PIN, high-grade, Prevention, prostatic intraepithelial neoplasia, risk, selenium, soy, vitamin E | 5 Comments »
Posted on November 10, 2010 by Sitemaster
The idea that the soy isoflavone known as genistein might prove to be a non-toxic therapeutic agent for the prevention and/or treatment of prostate cancer has now been around for so long that the idea appears to have become a perceived truth in some quarters. … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer | Tagged: genistein, isoflavone, outcome, soy, trial | Leave a comment »
Posted on October 28, 2010 by Sitemaster
Soy isoflavones are known to have antioxidant and anti-inflammatory activities and to sensitize prostate cancer cells to radiation therapy. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: adverse effects, complications, isoflavone, radiation therapy, soy | 1 Comment »
Posted on March 15, 2009 by Sitemaster
We have added information about three more recent studies for your weekend reading, dealing with:
- Soy, diet, and prostate cancer prevention
- Outcomes of bladder neck preservation during radical prostatectomy
- A predictive model for chemotherapy outcomes in HRPC patients … READ MORE …
Filed under: Drugs in development, Management, Prevention, Treatment | Tagged: bladder neck preservation, chemotherapy, diet, hormone-refractory prostate cancer, nomogram, outcome, Prevention, risk, soy | Leave a comment »
Posted on February 25, 2009 by Sitemaster
Our second report today deals with:
- Soy isoflavone concentration in prostate cancer tissue
- A new vitamin E ether analog and its activity in the laboratory
- PSA “half-life” as a prognostic indicator for impact of hormone therapy
- Apolipoprotein C-I: is it important hormone-refractory prostate cancer?
- Chemotherapeutic sensitization and its possible impact on taxane therapy … READ MORE …
Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Prevention, Risk, Uncategorized | Tagged: apolipoprotein, chemotherapy, isoflavone, prognosis, PSA "half-life", sensitization, soy, taxane, VEBSA, vitamin E analog | Leave a comment »
Posted on February 8, 2009 by Sitemaster
An article by Collins on the CalorieLab web site offers a sound summary of “where we are” (or perhaps more accurately “where we aren’t”) with regard to the use of supplements in the prevention of prostate cancer. … READ MORE …
Filed under: Prevention | Tagged: flaxseed, garlic, green tea, isothiocyanate, lycopene, milk, pomegranate, risk, selenium, soy, supplements, vitamin | Leave a comment »
Posted on January 20, 2009 by Sitemaster
Today’s inauguration day (here in the USA) news reports address:
- Obesity and prostate cancer screening PSA levels
- The possible association of bone mineral density with prostate cancer risk in older men
- Soy, genistein, and the inhibition of prostaglandins
- Pathologic prostate specimen weight and perioperative outcomes in LRP … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: bone mineral density, Diagnosis, genistein, LRP, obesity, outcomes, prostaglandin, prostate weight, PSA levels, risk, soy | Leave a comment »